Research Partnership launches new patient Living with Non-alcoholic Steatohepatitis (NASH) report
Research Partnership launches new patient report - Living with Non-alcoholic Steatohepatitis (NASH)
Living with Non-alcoholic Steatohepatitis (NASH) is a study conducted amongst 100 adults with NASH in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase summer 2017.
The report is intended to help pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with NASH, how it impacts their day-to-day lives and what their attitudes and perceptions are towards the management of their condition. It will also uncover attitudes towards NASH compared to other co-morbid conditions such as diabetes and obesity.
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD) in which inflammation and liver cell damage exists in addition to fat in the liver. It can lead to complications, such as cirrhosis and liver cancer.
Prevalence of NASH (which is estimated to be 6% in the US) is linked to obesity and Type 2 diabetes and as these two conditions increase in prevalence, NASH is also expected to become more common. Head of Living with, Mariel Metcalfe commented, “We are pleased to conduct this study, especially given the great need that exists in understanding the journey of those living with NASH from pre-diagnosis to current management. This report will provide comprehensive, quantitative insights into patient behaviours and also their feelings at key stages of their journey.”
Currently being conducted in the US but looking to expand the survey to the EU, Living with NASH is just one in a series of reports offering comprehensive insight into the chronic disease patient journey from pre-diagnosis to stabilisation. Living with Lupus (SLE) (EU & US), Living with Crohn’s (EU & US), Rheumatoid Arthritis (EU & US) and PsA (EU) reports have recently been published and are available to purchase.
Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »